Envoy Medical (COCH) Net Cash Flow (2021 - 2026)

Envoy Medical has disclosed Net Cash Flow across 6 years of filings, most recently posting -$5.6 million for Q2 2026.

• In Q2 2026, Net Cash Flow fell 24095.65% year-over-year to -$5.6 million; the TTM figure through Jun 2026 stood at $14.4 million (up 306.92% YoY), while the FY2025 annual figure was -$1.7 million, down 237.67% from the prior year.
• Net Cash Flow came in at -$5.6 million for Q2 2026 at Envoy Medical, down from $21.5 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $21.5 million in Q1 2026 to a low of -$12.6 million in Q4 2023.
• Average Net Cash Flow over 5 years is $1.0 million, with a median of -$22870.0 recorded in 2022.
• The largest YoY upside for Net Cash Flow was 12254.24% in 2026 against a maximum downside of 24095.65% in 2026.
• Over 5 years, Net Cash Flow stood at -$420000.0 in 2022, then tumbled by 2904.76% to -$12.6 million in 2023, then surged by 108.4% to $1.1 million in 2024, then slumped by 82.74% to $183000.0 in 2025, then sank by 3140.98% to -$5.6 million in 2026.
• Per Business Quant data, the three most recent Net Cash Flow figures were -$5.6 million in Q2 2026, $21.5 million in Q1 2026, and $183000.0 in Q4 2025.